Skip to Main content Skip to Navigation
Journal articles

Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

V. Cottin 1, 2 E. Bel 3 P. Bottero K. Dalhoff 4 M. Humbert 5 R. Lazor 6 R.A. Sinico P. Sivasothy 7 M.E. Wechsler 8 M. Groh S. Marchand-Adam 9 C. Khouatra B. Wallaert 10 C. Taillé 11 P. Delaval 12 J. Cadranel 13, 14 P. Bonniaud 15, 16, 17 G. Prévot S. Hirschi A. Gondouin B. Dunogué G. Chatté C. Briault C. Pagnoux D. Jayne L. Guillevin J.-F. Cordier 18, 19
Abstract : Objective To guide nosology and classification of patients with eosinophilic granulomatosis with polyangiitis (EGPA) based on phenotype and presence or absence of ANCA. Methods Organ manifestations and ANCA status were retrospectively analyzed based on the presence or not of predefined definite vasculitis features or surrogates of vasculitis in patients asthma, eosinophilia, and at least one systemic organ manifestation attributable to systemic disease. Results The study population included 157 patients (mean age 49.4 ± 14.1), with a follow-up of 7.4 ± 6.4 years. Patients with ANCA (31%) more frequently had weight loss, myalgias, arthralgias, biopsy-proven vasculitis, glomerulonephritis on biopsy, hematuria, leukocytoclastic capillaritis and/or eosinophilic infiltration of arterial wall on biopsy, and other renal disease. A total of 41% of patients had definite vasculitis manifestations (37%) or strong surrogates of vasculitis (4%), of whom only 53% had ANCA. Mononeuritis multiplex was associated with systemic vasculitis (p = 0.005) and with the presence of ANCA (p < 0.001). Overall, 59% of patients had polyangiitis as defined by definite vasculitis, strong surrogate of vasculitis, mononeuritis multiplex, and/or ANCA with at least one systemic manifestation other than ENT or respiratory. Patients with polyangiitis had more systemic manifestations including arthralgias (p = 0.02) and renal disease (p = 0.024), had higher peripheral eosinophilia (p = 0.027), and a trend towards less myocarditis (p = 0.057). Using predefined criteria of vasculitis and surrogates of vasculitis, ANCA alone were found to be insufficient to categorise patients with vasculitis features. Conclusion We suggest a revised nomenclature and definition for EGPA and a new proposed entity referred to as hypereosinophilic asthma with systemic (non vasculitic) manifestations. © 2016 Elsevier B.V.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01467544
Contributor : Xavier Chard-Hutchinson <>
Submitted on : Tuesday, February 14, 2017 - 3:22:52 PM
Last modification on : Wednesday, August 19, 2020 - 11:17:22 AM

Identifiers

Citation

V. Cottin, E. Bel, P. Bottero, K. Dalhoff, M. Humbert, et al.. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmunity Reviews, Elsevier, 2017, 16 (1), pp.1--9. ⟨10.1016/j.autrev.2016.09.018⟩. ⟨hal-01467544⟩

Share

Metrics

Record views

484